Attenuated expression of DFFB is a hallmark of oligodendrogliomas with 1p-allelic loss

Molecular Cancer

Volumn 4, Issue , 2005, Pages

  McDonald, J Matthew ^a   Dunmire, Valerie ^a   Taylor, Ellen ^a   Sawaya, Raymond ^a   Bruner, Janet ^a   Fuller, Gregory N ^a   Aldape, Kenneth ^a   Zhang, Wei ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; PROTEIN P73; PROTEIN SUBUNIT; REGULATOR PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; DEOXYRIBONUCLEASE; DFFB PROTEIN, HUMAN; MESSENGER RNA;

ALLELE; APOPTOSIS; ARTICLE; CANCER SCREENING; CARCINOGENESIS; CHROMOSOME 1P; CHROMOSOME DELETION; CHROMOSOME LOSS; CONTROLLED STUDY; FREQUENCY ANALYSIS; GENE MAPPING; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; OLIGODENDROGLIOMA; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; CHROMOSOME 1; GENE EXPRESSION REGULATION; GENETICS; HETEROZYGOSITY LOSS; METABOLISM;

CHROMOSOMES, HUMAN, PAIR 1; DEOXYRIBONUCLEASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LOSS OF HETEROZYGOSITY; OLIGODENDROGLIOMA; RNA, MESSENGER;

EID: 26844440729     PISSN: 14764598     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-4-35     Document Type: Article

References (16)

1. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP: Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994, 145:1175-1190.
2. Bello MJ, Vaquero J, de Campos JM, Kusak ME, Sarasa JL, Saez-Castresana J, Pestana A, Rey JA: Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors. Int J Cancer 1994, 57:172-175.
3. Bello MJ, Leone PE, Vaquero J, de Campos JM, Kusak ME, Sarasa JL, Pestana A, Rey JA: Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int J Cancer 1995, 64:207-210.
4. Kraus JA, Koopmann J, Kaskel P, Maintz D, Brandner S, Schramm J, Louis DN, Wiestler OD, von Deimling A: Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 1995, 54:91-95.
5. Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G, Hosek SM, Kimmel D, O'Fallon J, Yates A, Feuerstein BG, Burger PC, Scheithauer BW, Jenkins RB: Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 1999, 18:4144-4152.
6. Husemann K, Wolter M, Buschges R, Bostrom J, Sabel M, Reifenberger G: Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors. J Neuropathol Exp Neurol 1999, 58:1041-1050.
7. Dong SM, Pang JC, Poon WS, Hu J, To KF, Chang AR, Ng HK: Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors. J Neuropathol Exp Neurol 2001, 60:808-816.
8. Dong Z, Pang JS, Ng MH, Poon WS, Zhou L, Ng HK: Identification of two contiguous minimally deleted regions on chromosome 1p36.31-p36.32 in oligodendroglial tumours. Br J Cancer 2004, 91:1105-1111.
9. Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M: Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Clin Cancer Res 2005, 11:1119-1128.
10. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000, 100:57-70.
11. Suzuki S, Moore DH, 2nd, Ginzinger DG, Godfrey TE, Barclay J, Powell B, Pinkel D, Zaloudek C, Lu K, Mills G, Berchuck A, Gray JW: An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res 2000, 60:5382-5385.
12. Ginzinger DG, Godfrey TE, Nigro J, Moore DH, 2nd, Suzuki S, Pallavicini MG, Gray JW, Jensen RH: Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res 2000, 60:5405-5409.
13. Nigro JM, Takahashi MA, Ginzinger DG, Law M, Passe S, Jenkins RB, Aldape K: Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay. Am J Pathol 2001, 158:1253-1262.
14. Wheeler DL, Church DM, Edgar R, Federhen S, Helmberg W, Madden TL, Pontius JU, Schuler GD, Schriml LM, Sequeira E, Suzek TO, Tatusova TA, Wagner L: Database resources of the National Center for Biotechnology Information: update. Nucleic Acids Res 2004, 32 Database issue:D35-40.
15. Kawane K, Fukuyama H, Yoshida H, Nagase H, Ohsawa Y, Uchiyama Y, Okada K, Iida T, Nagata S: Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation. Nat Immunol 2003, 4:138-144.
16. Judson H, van Roy N, Strain L, Vandesompele J, Van Gele M, Speleman F, Bonthron DT: Structure and mutation analysis of the gene encoding DNA fragmentation factor 40 (caspase-activated nuclease), a candidate neuroblastoma tumour suppressor gene. Hum Genet 2000, 106:406-413.